From granted patent to new revenue.
Four situations. Each starts with a fixed-fee read.
Built for security, identity, and trust technology: hardware security, cryptography, identity and access, payments and fraud, and regulated markets.
No pitch yet
Your patent is granted and the engineering is real. Nobody outside engineering can explain what it is or why anyone would buy it.
Your inventor can explain the mechanism. Nobody can explain the product. The Patent to Product Read turns the granted claims and the engineering into a named product, a pitch, and a deck your CEO can present without the inventor in the room.
The read
Two to three weeks, fixed fee
Patent to Product Read
You will walk out with a product a non-engineer can pitch: named, mapped to your claims, drawn where it is hardware, and ready for the room.
For A founder-inventor or CEO heading into investor or partner conversations in the next two quarters, with a granted patent, real engineering, and no product concept beyond the claims; and the investors behind them who need the company to be able to say what it sells.
No market answer yet
Your patent tells you what you own. It does not tell you who pays, what for, or how to reach them. Patenture answers that.
A granted patent and no commercial answer yet. The Claim to Market Read tells you which use cases your claims reach and which of them anyone will pay for.
The read
Two to three weeks, fixed fee
Claim to Market Read
You will find out which of your use cases your patent actually covers, and which of them anyone will pay for, before you spend another dollar on either.
For A founder-inventor or CEO with a granted patent, often a pending continuation, and no commercial answer yet; the investors behind them; and the counsel who wants the commercial questions asked before the continuation is drafted.
Then
Ninety days, fixed fee
Commercial Viability Assessment
A board-grade answer to whether, where, and how your technology becomes a product someone pays for, with the investor briefing, the partner briefing, and the board recommendation to act on it.
For A company that has settled which use cases its claims reach and now needs the buyer, the price, the partner ladder, and the board case, validated with the people who would buy it.
Then
Monthly, quoted per engagement
Commercialization Lead
The plan the Assessment produced, run by the operator who wrote it, with a stop date and a defined handoff.
For A company with a recommendation in hand and no commercial leader yet in the seat, whose board wants the first licensees, design partners, and pricing tests run by someone who has done it before.
Already in market
Your product uses the patent. Your claims reach further.
Your product uses part of what your claims cover. The rest can earn in markets you will never sell into, licensed to companies that will never compete with you. The Licensing Reach Read finds them and screens every one against your own customers and partners first.
The read
About three weeks, fixed fee
Licensing Reach Read
You will find out where your claims reach beyond your own product, who would license that reach, and which of those deals your own customers and partners would never notice.
For An operating company that ships the patented technology in its own product, whose claims cover fields, channels, form factors, or regions it will never sell into; and the board or corporate development lead who wants that reach earning without creating a competitor.
Then
Monthly, quoted per engagement
Licensing Program
The licensee ladder the Read produced, worked by the operator who built it, with a stop date and your counsel closing every license.
For A company with a ranked licensee ladder in hand and no one inside whose job it is to work it, that wants licensing revenue from markets it will never enter while keeping title and keeping its customer relationships clean.
Market already known
You know who needs it. We get you in the room.
You already know who needs your patent. What you need is the package that earns a meeting, the relationships that get you into the room, and someone to run the process to a term sheet. The Mandate Review tests the thesis first, in about a week.
The review
About one week, fixed fee
Mandate Review
A plain answer on whether your market thesis holds against your claims and the people who would buy, and whether we would take the mandate.
For A patent owner who already knows who needs the patent and wants it licensed or sold: a founder, an operating company divesting non-core patents, or an inventor whose patents fall below what a broker will take.
Then
Fixed setup fee, then monthly for a set term
Licensing and Sale Mandate
Your patent packaged, pitched through the relationships that get it into the room, and run to a term sheet, with your counsel closing.
For An owner whose thesis has passed the Mandate Review and who wants a license or a sale run by someone who has pitched patent portfolios to strategic acquirers and licensees before.
The go-to-market that follows
Where the technology needs a go-to-market built after the deal, that is the Commercialization Lead, run by the operator who wrote the plan.
Pricing tested in market, the partner ladder worked top to bottom, the first commercial hires made, and a board update each period. It ends at a defined handoff: a commercial leader in the seat, or a motion your own team can run.
How we get paid
Every read is a fixed fee, quoted before we start. Programs are scoped per engagement. Where Patenture brings the licensee or partner, part of the fee can ride on the revenue that relationship produces.
Brokers pass on most patents. The ones they take, they list and wait. None of them will give your patent a product vision or explain it to a business buyer. That is where Patenture starts.
Patenture is not a law firm. The claim explainer and the counsel question list are commercial analysis; claim construction, validity, and prosecution strategy stay with your patent counsel, whose access is a condition of the engagement.
Not sure which door is yours?
Twenty minutes is enough to tell which read fits, or whether none does yet.